Rezolute, Inc. (RZLT) Stock Forecast

NASDAQ: RZLTAnalyst ratings, price target and estimates.

RZLT analyst forecast

as of October 17, 2026
Analyst consensus
Strong buy
4.82 / 5 from 11 analysts
Price target
$9.80
average of analyst targets
Upside to target
+173.7%
from the latest close
Next earnings
November 5, 2026
EPS estimate $-0.18
52-week range
$1.40 – $10.94

RZLT analyst ratings

11 analysts
Strong buy
982%
Buy
218%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

RZLT price target

Price $3.58Target $9.80
52-week low $1.4052-week high $10.94

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

RZLT earnings per share estimates

Rezolute, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.18−$0.21−$0.15−$0.18−2.8%8
Next quarter (Dec '26)−$0.17−$0.21−$0.14−$0.22+23.9%8
Current fiscal year (FY2027)−$0.70−$0.84−$0.57−$0.75+7.0%9
Next fiscal year (FY2028)−$0.47−$0.97−$0.15−$0.70+32.9%7

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

RZLT revenue estimates

Rezolute, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$0$0$00.0%10
Next quarter (Dec '26)$0$0$00.0%10
Current fiscal year (FY2027)$2.1M$0$23.0M0.0%11
Next fiscal year (FY2028)$54.1M$3.9M$186.3M+2,482.3%10

RZLT EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

RZLT revenue: reported and forecast

Reported revenueEstimate (average; low–high)

RZLT EPS estimate revisions

Rezolute, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.15−$0.15−$0.15−$0.18−$0.18+26.7%0 up · 4 down
Next quarter (Dec '26)−$0.13−$0.13−$0.13−$0.17−$0.17+30.9%0 up · 4 down
Current fiscal year (FY2027)−$0.63−$0.63−$0.63−$0.70−$0.70+11.4%1 up · 4 down
Next fiscal year (FY2028)−$0.28−$0.28−$0.28−$0.47−$0.47+67.4%1 up · 3 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

RZLT earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; RZLT beat in 6 of 12.

What analysts expect from RZLT

11 analysts cover Rezolute; their consensus rating is strong buy (4.82 on a 1–5 scale, where 5 is a strong buy). The average price target is $9.80, 173.7% above the latest close of $3.58. Analysts expect earnings of −$0.70 per share for FY2027, +7.0% from a year earlier. For FY2028 the average estimate is −$0.47 per share on revenue of $54.1 million. Rezolute beat the EPS estimate in 6 of the last 12 quarters.

Related: RZLT income statement, RZLT key metrics, RZLT chart. See the RZLT stock overview for the latest quote and news.

RZLT forecast FAQ

What is Rezolute's price target?

The average analyst price target for Rezolute is $9.80, 173.7% above the latest close of $3.58.

Is Rezolute a buy, hold or sell?

Of 11 analysts covering Rezolute, 9 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Rezolute's EPS forecast?

Analysts forecast −$0.70 per share for FY2027 (range −$0.84 to −$0.57); for FY2028 the estimate is −$0.47.

What is Rezolute's revenue forecast?

The average revenue estimate for FY2027 is $2.1 million, growth of 0.0%; for FY2028 it is $54.1 million.

When does Rezolute report earnings?

Rezolute is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $-0.18.

Does Rezolute usually beat earnings estimates?

Rezolute reported EPS at or above the analyst estimate in 6 of the last 12 quarters.

Biotechnology: forecast